Hedge Fund Stock Picks & Ticker Coverage
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Moerus Capital Management LLC Amit Wadhwaney | “Natura Cosméticos, the Brazil-based beauty products retailer, was the most significant detractor from performance back in 2025, as cyclically weak consumer spending in Brazil – driven by inflation and high interest rates (currently 14.25%) that have pressured disposable incomes – as well as costs associated with the company's ongoing business restructuring weighed on shares last year. As we noted at the time, we believe that the weak consumer environment will eventually improve, while Natura's recent jettisoning of non-core business units and renewed focus on its core brands are positive developments for the long-term investment thesis, which we believe remains attractive. Accordingly, we added to the Fund's position in Natura in 2025 and early in 2026. Natura shares rebounded in early 2026, before advancing further after the March 30th announcement that private equity investor Advent International intended to buy an 8% to 10% stake in Natura in the market over the following six months, aiming at an average purchase price of BRL 9.75 per share. Upon purchasing said stake, Advent would be entitled to appoint two members to Natura's board of directors. Also under the proposal, Alessandro Carlucci, former CEO who led Natura during some of its most successful years, would become Chair of a reconstituted board. Natura also announced that its three founders and former CEO Fabio Barbosa would move from the board to a newly formed advisory board, leaving day-to-day decision-making powers to the board of directors. The announcement of an interested financial investor with experience investing in the Brazilian beauty space was well received by the market, as was the proposed board refresh, which at the same time addressed the succession plan of the company's founders. Not surprisingly, the news was well received by investors. With that said, Natura shares subsequently gave back some of their previous YTD gains in the Second Quarter, driven by a Brazilian equity market that saw significant foreign investor outflows, as well as by the persistence of the challenging consumer spending environment, which has weighed on the company's results as management continues to streamline the business and refocus on the company's core brands and markets. While this process will likely take some more time, we believe Natura is making progress that shareholders will ultimately benefit from over the long run. Subsequent to the close of H1, it was announced in July 2026 that Advent International had indeed acquired an 8% economic interest in Natura.” | BEAR | Q2 2026 Aug 14, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.